中國水務(00855.HK)擬認購康達國際環保可交換債券
格隆匯4月1日丨中國水務(00855.HK)發佈公告,2020年4月1日,公司(為認購人)與BPEA(為發行人)訂立認購協議,據此,公司有條件同意認購及BPEA有條件同意發行可交換債券,代價約為港幣3.61億元。代價將透過由公司向 BPEA發行可換股債券,以按每股轉換股份港幣8.05元的初步轉換價轉換為最多約4488.65萬股轉換股份的方式償付。
可交換債券將初步賦予其持有人權利交換得BPEA於交換權行使日期所擁有的約3.44億股康達股份(相當於康達國際全部已發行股本約16.93%)。公司將於建議認購事項完成後提名公司全資附屬公司Sharp Profit為可交換債券的持有人。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.